Sign in

CIK 0001801170 · Large accelerated filer

CLOVER HEALTH INVESTMENTS, CORP. /DE

Sign in to watch
Ticker
CLOV
Exchange
Nasdaq
Industry
Hospital & Medical Service Plans
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
981515192
Phone
(201) 432-2133
Business address
30 MONTGOMERY STREET, JERSEY CITY, NJ, 07302
Former names
Social Capital Hedosophia Holdings Corp. III
  1. 4 Grant or award Chief Accounting Officer acquired 186,403 shares (grant or award)
  2. 4 Grant or award Chief Financial Officer acquired 328,947 shares (grant or award)
  3. 4 Planned sale Chief Legal Officer sold 19,275 shares at $4.66 ($89,822)
  4. 4 Planned sale CEO, Medicare Advantage sold 4,066 shares at $4.41 ($17,931)
  5. 4 Planned sale Chief Executive Officer sold 62,176 shares at $4.68 ($290,984)
  6. 4 Planned sale Chief Legal Officer sold 14,673 shares at $4.68 ($68,670)
  7. 4 Planned sale Interim CFO sold 4,591 shares at $4.68 ($21,486)
  8. 4 Planned sale CEO, Counterpart Health sold 23,627 shares at $4.68 ($110,574)
  9. 4 Planned sale CEO, Medicare Advantage sold 18,273 shares at $4.68 ($85,518)
  10. 4 Planned sale CEO, Medicare Advantage sold 2,006 shares at $4.63 ($9,288)
  11. 4 Planned sale CEO, Medicare Advantage sold 8,750 shares at $4.42 ($38,675)
  12. 4 Grant or award Director acquired 12,481 shares (grant or award)
  13. 4 Grant or award Director acquired 12,481 shares (grant or award)
  14. 4 Planned sale Chief Executive Officer sold 318,806 shares at $4.19 ($1,335,797)
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 4 Planned sale CEO, Medicare Advantage sold 1,921 shares at $4.56 ($8,760)
  18. 4 Planned sale VP OF FINANCE AND CONTROLLER sold 3,170 shares at $4.64 ($14,709)
  19. 4 Planned sale CEO, Counterpart Health sold 300,000 shares at $4.72 ($1,416,000)
  20. 4 Planned sale Chief Legal Officer sold 6,846 shares at $4.78 ($32,724)

Page 1 of 18 · 351 filings